Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial

Breelyn A. Wilky(Sylvester Comprehensive Cancer Center), Matteo Trucco(University of Miami), Ty K. Subhawong(University of Miami), Vaia Florou(University of Miami), Wungki Park(University of Miami), Deukwoo Kwon(Sylvester Comprehensive Cancer Center), Eric Wieder(University of Miami), Despina S. Kolonias(Sylvester Comprehensive Cancer Center), Andrew E. Rosenberg(University of Miami), Darcy A. Kerr(University of Miami), Efrosyni Sfakianaki(University of Miami), Mark K. Foley(University of Miami), Jaime R. Merchan(Sylvester Comprehensive Cancer Center), Krishna V. Komanduri(University of Miami), Jonathan C. Trent(University of Miami)
The Lancet Oncology
May 9, 2019
Cited by 383

Abstract


Related Papers

No related papers found

Powered by citation graph analysis